Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 20, 2026
Continuous versus intermittent infusion of high-dose meropenem in critically ill patients: an observational cohort study
Felix Bergmann, Marlene Prager, Katarina Kumpf, et al.
Thrombosis Journal
|
April 15, 2022
Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial
Georg Gelbenegger, Juergen Grafeneder, Gloria M Gager, et al.
Cardiovascular Diabetology
|
May 20, 2024
Association of prediabetes with clinical outcomes in patients with chronic coronary syndrome: a post hoc analysis of the ISCHEMIA and ISCHEMIA-CKD trials
Anselm Jorda, Christian Hengstenberg, Irene M Lang, et al.
Scientific Reports
|
July 9, 2020
The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin
Katarina D Kovacevic, Nina Buchtele, Christian Schoergenhofer, et al.
Infection
|
June 16, 2023
Community-acquired and hospital-acquired bacterial co-infections in patients hospitalized with Covid-19 or influenza: a retrospective cohort study
Anselm Jorda, Cornelia Gabler, Amelie Blaschke, et al.
British Journal of Haematology
|
June 2, 2022
Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial
Georg Gelbenegger, Ulrich Jaeger, Michael Fillitz, et al.
BMC Medicine
|
November 5, 2019
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
Georg Gelbenegger, Marek Postula, Ladislav Pecen, et al.
Frontiers in Cardiovascular Medicine
|
July 25, 2022
Association Between the Expression of MicroRNA-125b and Survival in Patients With Acute Coronary Syndrome and Coronary Multivessel Disease
Gloria M Gager, Ceren Eyileten, Marek Postula, et al.
Thrombosis and Haemostasis
|
June 5, 2018
Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia
Christian Schoergenhofer, Michael Schwameis, Georg Gelbenegger, et al.
Scientific Reports
|
August 2, 2019
Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers
Christian Schoergenhofer, Nina Buchtele, Georg Gelbenegger, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 20, 2026
Continuous versus intermittent infusion of high-dose meropenem in critically ill patients: an observational cohort study
Felix Bergmann, Marlene Prager, Katarina Kumpf, et al.
Thrombosis Journal
|
April 15, 2022
Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial
Georg Gelbenegger, Juergen Grafeneder, Gloria M Gager, et al.
Cardiovascular Diabetology
|
May 20, 2024
Association of prediabetes with clinical outcomes in patients with chronic coronary syndrome: a post hoc analysis of the ISCHEMIA and ISCHEMIA-CKD trials
Anselm Jorda, Christian Hengstenberg, Irene M Lang, et al.
Scientific Reports
|
July 9, 2020
The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin
Katarina D Kovacevic, Nina Buchtele, Christian Schoergenhofer, et al.
Infection
|
June 16, 2023
Community-acquired and hospital-acquired bacterial co-infections in patients hospitalized with Covid-19 or influenza: a retrospective cohort study
Anselm Jorda, Cornelia Gabler, Amelie Blaschke, et al.
British Journal of Haematology
|
June 2, 2022
Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial
Georg Gelbenegger, Ulrich Jaeger, Michael Fillitz, et al.
BMC Medicine
|
November 5, 2019
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
Georg Gelbenegger, Marek Postula, Ladislav Pecen, et al.
Frontiers in Cardiovascular Medicine
|
July 25, 2022
Association Between the Expression of MicroRNA-125b and Survival in Patients With Acute Coronary Syndrome and Coronary Multivessel Disease
Gloria M Gager, Ceren Eyileten, Marek Postula, et al.
Thrombosis and Haemostasis
|
June 5, 2018
Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia
Christian Schoergenhofer, Michael Schwameis, Georg Gelbenegger, et al.
Scientific Reports
|
August 2, 2019
Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers
Christian Schoergenhofer, Nina Buchtele, Georg Gelbenegger, et al.
Page
of 6